Source Octreotide Acetate Powder for Pharmaceutical, Research, and Clinical Uses

Strategic Sourcing Guide for Octreotide Acetate Powder

Procuring high-purity Octreotide Acetate powder requires a disciplined approach that balances chemical precision with rigorous supply chain verification. For buyers in the pharmaceutical sector, the core keyword "octreotide acetate powder" represents a critical active pharmaceutical ingredient (API) used in complex therapeutic formulations. The market data indicates a diverse landscape of suppliers offering products with varying specifications, from fine powders to specific injection-grade forms. This guide synthesizes observed product attributes, compliance standards, and technical parameters to provide a robust framework for procurement decisions. Buyers must navigate a range of observed price points from 1 to 290 USD and minimum order quantities (MOQ) ranging from 1 to 100 units, necessitating a clear understanding of how these variables correlate with quality and certification status.

Technical Specifications and Chemical Identity

The foundational step in sourcing Octreotide Acetate is verifying the precise chemical identity and physical properties of the material. The primary identifier for this compound is the CAS Registry Number 83150-76-9, which distinguishes it from related analogs such as those with the CAS number 79517-01-4. Buyers must ensure that the supplier explicitly lists this CAS number to avoid confusion with structurally similar compounds. The molecular formula for the standard Octreotide Acetate is C49H66N10O10S2, with a molecular weight of 1019.24700. These numerical values are non-negotiable for regulatory compliance and must be cross-referenced against the Certificate of Analysis (COA) provided by the vendor.

Physical attributes observed in the market include a white to off-white solid powder appearance, often described as a fine powder. The density is recorded at 1.395, and the LogP value is approximately 3.02100, indicating specific lipophilicity characteristics relevant to formulation stability. While some listings describe the product form as an "Injection," this typically refers to the intended end-use application rather than the physical state of the raw powder supplied. The standard purity threshold for high-grade material is observed at greater than 99%, a benchmark that must be verified through specific test methods like High-Performance Liquid Chromatography (HPLC). Buyers should note that while some entries list the molecular formula as C32H35ClN18O10S6, this corresponds to a different chemical entity (CAS 79517-01-4) and requires distinct verification to ensure the correct octreotide acetate is being sourced.

Compliance, Certification, and Regulatory Standards

Navigating the regulatory landscape is paramount when sourcing pharmaceutical-grade ingredients. The market data highlights a variety of certifications, including BP (British Pharmacopoeia), USP (United States Pharmacopeia), ISO HSE, and GMP (Good Manufacturing Practice). A compliant supplier should be able to provide documentation proving adherence to GMP standards, which is frequently listed as a primary product standard. The presence of USP and BP certifications suggests that the material meets specific international pharmacopeial monographs, which is essential for products destined for markets in North America, Europe, and other regulated regions.

When evaluating a supplier, buyers must distinguish between general quality claims and specific certification status. The observed data includes references to "GMP" as both a certification and a product standard, indicating that the manufacturing facility likely adheres to these protocols. However, the specific scope of these certifications must be verified. For instance, while some listings mention "HSE" (Health, Safety, and Environment), this is distinct from pharmaceutical quality certifications. Buyers should request current, valid certificates from the specific manufacturing site rather than relying on generic claims. The standard purity of 99% is often cited as a product standard, but this should be treated as a target specification rather than a guaranteed outcome without a batch-specific COA.

Cost Drivers and Pricing Variables

The pricing structure for Octreotide Acetate powder is influenced by several dynamic factors, including purity levels, certification scope, and order volume. The observed price range in the market spans from 1 to 290 USD, a wide variance that reflects differences in packaging, quantity, and supplier tier. The Minimum Order Quantity (MOQ) varies significantly, ranging from 1 unit to 100 units. Lower MOQs, such as 1 unit, are often associated with sample orders or specialized small-batch customizations, while higher MOQs typically correlate with bulk pricing and standard industrial packaging.

Cost drivers also include the level of customization requested. The market data indicates that customization is available for some suppliers, while others offer non-customized, standard stock items. Customized orders, which may involve specific packaging formats like "0.1mg10bottles100box/Carton," generally incur higher costs due to the additional labor and quality control steps required. Furthermore, the origin of the product, with Xian and China cited as primary locations, can influence logistics costs and lead times. Buyers should analyze the total cost of ownership, factoring in transportation methods (e.g., Air) and delivery times, which are observed to range from 7 to 15 days. The loading level of 120% mentioned in some contexts suggests specific logistical constraints or capacity utilization that may affect shipping efficiency and cost.

Typical Applications and Suitability Profiles

Octreotide Acetate powder is primarily utilized in the pharmaceutical industry for the development of therapeutic formulations. The product is suitable for a broad demographic, including adults, children, and the elderly, which necessitates rigorous quality control to ensure safety across all age groups. The specific application is listed as "Pharmaceutical," indicating its role as an API in drug manufacturing rather than a direct consumer product. The chemical synthesis process, identified as the primary pharmaceutical technology, ensures the production of the active ingredient required for various medical treatments.

The versatility of the product is further highlighted by its suitability for different patient populations. When sourcing for pediatric or geriatric formulations, buyers must ensure that the supplier's quality control protocols specifically address the purity and impurity profiles required for these sensitive demographics. The "Injection" form mentioned in some product descriptions suggests that the powder is intended for reconstitution into injectable solutions. This application requires the powder to meet stringent sterility and solubility standards, which are often verified through the specific test methods employed by the manufacturer. Buyers should verify that the supplier has experience in producing material suitable for injectable formulations, as this involves additional regulatory scrutiny compared to oral or topical applications.

Supplier Evaluation and Quality Control Protocols

Evaluating a supplier for Octreotide Acetate requires a multi-faceted approach focusing on documentation, testing capabilities, and logistical reliability. The presence of a COA (Certificate of Analysis) is a critical requirement, serving as the primary evidence of product quality. The test method specified as HPLC is the industry standard for verifying purity and identifying impurities. Buyers should request a detailed COA for every batch purchased, ensuring that the test results align with the stated purity of >99% and the specific molecular characteristics.

Quality control extends beyond the final product to the manufacturing process. The observed data indicates that the product is produced via chemical synthesis, a process that must be tightly controlled to prevent batch-to-batch variability. Suppliers should be able to demonstrate their adherence to GMP standards throughout the synthesis and packaging phases. The shelf life of the product is typically 2 years, a parameter that must be clearly stated on the packaging and in the COA. Additionally, the packaging format, ranging from "Carton" to "Standard Export Package," must be suitable for maintaining the stability of the powder during transit. Buyers should verify that the packaging is designed to protect the material from moisture and light, which can degrade the chemical integrity of the powder over time.

Long-Term Procurement Considerations

Sourcing Octreotide Acetate is not merely a transactional activity but a strategic partnership that impacts long-term supply chain stability. The availability of customization options allows buyers to tailor the product to specific formulation needs, but this requires a supplier with flexible manufacturing capabilities. The lead time of 7-15 days is a critical factor for production planning, and buyers should assess the supplier's ability to maintain this timeline during periods of high demand. Transportation methods, such as air freight, offer speed but may increase costs; buyers must balance these factors based on their inventory requirements.

Long-term procurement also involves monitoring the supplier's ability to maintain consistent quality. The observed variation in product models, such as "HNR-Octreotide Acetate" and "OAI," suggests that different suppliers or product lines may have distinct characteristics. Buyers should establish a standardized specification sheet that includes CAS numbers, purity thresholds, and packaging requirements to ensure consistency across orders. Furthermore, the "Loading Level" of 120% mentioned in some contexts may indicate specific logistical capabilities that could be advantageous for large-scale shipments. By maintaining a clear understanding of these variables and fostering transparent communication with suppliers, buyers can mitigate risks and ensure a reliable supply of high-quality Octreotide Acetate powder for their pharmaceutical operations.

Comparative Analysis of Product Attributes

To facilitate informed decision-making, the following table summarizes key attributes observed across the market for Octreotide Acetate powder. This comparison highlights the variability in specifications and helps buyers identify the parameters that align with their specific procurement needs.

This structured approach to sourcing ensures that buyers can navigate the complexities of the Octreotide Acetate market with confidence, prioritizing quality, compliance, and supply chain reliability.